In the past, this section of EyeWorld has delved into nuanced glaucoma subtypes. In this issue, Won Kim, MD, and Maria Charria, MD, get into the specifics related to traumatic glaucoma. There are many ...
When it comes to refractive procedures, there are many options available. Several physicians discussed what they’re using and the options available, notably market penetration of the Implantable ...
The DSLT laser (Voyager, Alcon) became commercially available in the U.S. earlier this year, and many surgeons are beginning to incorporate this into their glaucoma treatment paradigm. Several ...
First-generation presbyopia-correcting IOLs established categories based on range of vision. Since then, there have been several iterations and additions within these categories, refining vision ...
Presbyopia-correcting eye drop receives FDA approval ➤ Four-year, first-in-human results for IOL-based drug delivery system ➤ FDA approves new treatment for thyroid eye disease ➤ New registry ...
Being successful in ophthalmology goes beyond just providing excellent clinical care, and learning and teaching has a ...
Epithelial thickness mapping was FDA approved in the U.S. in 2017, but awareness about its utility—and in some minds, its necessity—is growing. Three international ophthalmologists—Francesco Carones, ...
Intraoperative refractive guidance systems is a term coined by Kevin M. Miller, MD, describing the technology offered to patients as an additional, out-of-pocket benefit for their cataract surgeries.
LASIK volumes in the U.S. have declined in the last year, but this isn’t necessarily a bad thing, according to several EyeWorld Editorial Board members who commented on their recent observations with ...
In the decade-plus since its approval, femtosecond laser-assisted cataract surgery (FLACS) has essentially divided cataract surgeons into two camps: loyal proponents and frequent users of the ...
There are many potential complications cataract surgeons need to prepare for in the OR. One of them is zonulopathy. “Recognizing zonulopathy and adopting strategies to mitigate zonular damage is ...
The IC-8 Apthera IOL (Bausch + Lomb) is now available in the U.S., and several surgeons shared how this technology fits into their practice and for which patients. Arthur Cummings, MD, also provided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results